A Phase 2, Open-Label Study to Evaluate the Safety, Microbiology and Pharmacokinetics of C16G2 Administered in Single or Multiple Oral Gel Doses to Healthy Adult Subjects

Trial Profile

A Phase 2, Open-Label Study to Evaluate the Safety, Microbiology and Pharmacokinetics of C16G2 Administered in Single or Multiple Oral Gel Doses to Healthy Adult Subjects

Completed
Phase of Trial: Phase II

Latest Information Update: 11 Jan 2017

At a glance

  • Drugs C 16G2 (Primary)
  • Indications Dental caries
  • Focus Adverse reactions
  • Sponsors C3 Jian
  • Most Recent Events

    • 15 Jul 2015 According to an C3 Jian media release, company announced that it has preliminary data from this trial.
    • 13 Jul 2015 Status changed from active, no longer recruiting to completed according to an C3 Jian media release.
    • 26 May 2015 Planned End Date changed from 1 Apr 2015 to 1 Aug 2015 as reported by ClinicalTrials.gov record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top